Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

1,521 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Characterization of beta cell and incretin function in patients with MODY1 (HNF4A MODY) and MODY3 (HNF1A MODY) in a Swedish patient collection.
Ekholm E, Shaat N, Holst JJ. Ekholm E, et al. Among authors: holst jj. Acta Diabetol. 2012 Oct;49(5):349-54. doi: 10.1007/s00592-011-0312-y. Epub 2011 Jul 16. Acta Diabetol. 2012. PMID: 21761282
Antidiabetogenic effect of glucagon-like peptide-1 (7-36)amide in normal subjects and patients with diabetes mellitus.
Gutniak M, Orskov C, Holst JJ, Ahrén B, Efendic S. Gutniak M, et al. Among authors: holst jj. N Engl J Med. 1992 May 14;326(20):1316-22. doi: 10.1056/NEJM199205143262003. N Engl J Med. 1992. PMID: 1348845
Insulinotropic actions of intravenous glucagon-like peptide-1 (GLP-1) [7-36 amide] in the fasting state in healthy subjects.
Qualmann C, Nauck MA, Holst JJ, Orskov C, Creutzfeldt W. Qualmann C, et al. Among authors: holst jj. Acta Diabetol. 1995 Mar;32(1):13-6. doi: 10.1007/BF00581038. Acta Diabetol. 1995. PMID: 7612912
Subcutaneous injection of the incretin hormone glucagon-like peptide 1 abolishes postprandial glycemia in NIDDM.
Gutniak MK, Linde B, Holst JJ, Efendić S. Gutniak MK, et al. Among authors: holst jj. Diabetes Care. 1994 Sep;17(9):1039-44. doi: 10.2337/diacare.17.9.1039. Diabetes Care. 1994. PMID: 7988303 Clinical Trial.
Effect of glucagon-like peptide-1 (proglucagon 78-107amide) on hepatic glucose production in healthy man.
Hvidberg A, Nielsen MT, Hilsted J, Orskov C, Holst JJ. Hvidberg A, et al. Among authors: holst jj. Metabolism. 1994 Jan;43(1):104-8. doi: 10.1016/0026-0495(94)90164-3. Metabolism. 1994. PMID: 8289665
Gastric emptying, glucose responses, and insulin secretion after a liquid test meal: effects of exogenous glucagon-like peptide-1 (GLP-1)-(7-36) amide in type 2 (noninsulin-dependent) diabetic patients.
Willms B, Werner J, Holst JJ, Orskov C, Creutzfeldt W, Nauck MA. Willms B, et al. Among authors: holst jj. J Clin Endocrinol Metab. 1996 Jan;81(1):327-32. doi: 10.1210/jcem.81.1.8550773. J Clin Endocrinol Metab. 1996. PMID: 8550773 Clinical Trial.
Glucagon-like peptide I enhances the insulinotropic effect of glibenclamide in NIDDM patients and in the perfused rat pancreas.
Gutniak MK, Juntti-Berggren L, Hellström PM, Guenifi A, Holst JJ, Efendic S. Gutniak MK, et al. Among authors: holst jj. Diabetes Care. 1996 Aug;19(8):857-63. doi: 10.2337/diacare.19.8.857. Diabetes Care. 1996. PMID: 8842604 Clinical Trial.
Gut incretin hormones in identical twins discordant for non-insulin-dependent diabetes mellitus (NIDDM)--evidence for decreased glucagon-like peptide 1 secretion during oral glucose ingestion in NIDDM twins.
Vaag AA, Holst JJ, Vølund A, Beck-Nielsen HB. Vaag AA, et al. Among authors: holst jj. Eur J Endocrinol. 1996 Oct;135(4):425-32. doi: 10.1530/eje.0.1350425. Eur J Endocrinol. 1996. PMID: 8921824
Effects of glucagon-like peptide-1 on islet function and insulin sensitivity in noninsulin-dependent diabetes mellitus.
Ahrén B, Larsson H, Holst JJ. Ahrén B, et al. Among authors: holst jj. J Clin Endocrinol Metab. 1997 Feb;82(2):473-8. doi: 10.1210/jcem.82.2.3728. J Clin Endocrinol Metab. 1997. PMID: 9024239
Novel MODY3 mutations in the hepatocyte nuclear factor-1alpha gene: evidence for a hyperexcitability of pancreatic beta-cells to intravenous secretagogues in a glucose-tolerant carrier of a P447L mutation.
Hansen T, Eiberg H, Rouard M, Vaxillaire M, Møller AM, Rasmussen SK, Fridberg M, Urhammer SA, Holst JJ, Almind K, Echwald SM, Hansen L, Bell GI, Pedersen O. Hansen T, et al. Among authors: holst jj. Diabetes. 1997 Apr;46(4):726-30. doi: 10.2337/diab.46.4.726. Diabetes. 1997. PMID: 9075819
1,521 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback